Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05479929 · ClinicalTrials.gov registry record
Work of Breathing Assessment in Triage Scale
A clinical trial of Cough and Hypoxemia, sponsored by CHRISTUS Health.
- Active
- Registry status
- 39
- Enrollment target
- 1
- Study location
NCT05479929: Active study of Cough and Hypoxemia, sponsored by CHRISTUS Health.
NCT05479929 is a study of Cough and Hypoxemia that is active but no longer recruiting, run by CHRISTUS Health. The registered enrollment target is 39 participants, below the 219-participant average among 12 other Cough trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05479929, a study of Cough and Hypoxemia, is active but no longer recruiting, sponsored by CHRISTUS Health.
- ACTIVE NOT RECRUITING
- Registry status
- 39 participants
- Enrollment target
- 1
- Study location
Study Summary
The proposed research study will be a prospective observational study designed to validate the Canadian Triage Assessment Scale (CTAS) in regard to work of breathing in patients in the emergency department. The investigators will assess inter-rater agreement between nurses \& emergency physicians for assessment of work of breathing.
Primary Outcome
The CTAS is utilized to qualitatively define work of breathing as severe, moderate, or mild. Kappa will be calculated to assess inter-rater reliability
Conditions Studied
Interventions
- OTHER Canadian Triage Assessment Scale (CTAS)
Study Locations (1)
Texas
- CHRISTUS Spohn Hospital - Corpus Christi
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2020-10-30 |
| Est. Completion | 2025-10 |
What the registry record for NCT05479929 still lists
NCT05479929 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 39 participants, a relatively small participant target, below the 219-participant average among 12 other Cough trials with a reported enrollment target (82% lower).
The record links to 5 conditions, with Cough appearing as the primary indexed condition, and to 1 intervention - of which Canadian Triage Assessment Scale (CTAS) is the first listed.
NCT05479929 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT05479929 about?
NCT05479929 is a clinical study titled "Work of Breathing Assessment in Triage Scale". The proposed research study will be a prospective observational study designed to validate the Canadian Triage Assessment Scale (CTAS) in regard to work of breathing in patients in the emergency department. The investigators will assess inter-rater agreement between nurses \& emergency physicians fo...
What is the current status of trial NCT05479929?
This trial is currently active not recruiting. The enrollment target is 39 participants. The study started on 2020-10-30. Estimated completion is 2025-10.
What conditions does trial NCT05479929 study?
This clinical trial studies the following conditions: Cough, Hypoxemia, Shortness of Breath, Respiratory Symptoms, Difficulty Breathing.
What interventions are being tested in trial NCT05479929?
The interventions under investigation include: Canadian Triage Assessment Scale (CTAS) (OTHER).
Who is sponsoring clinical trial NCT05479929?
This trial is sponsored by CHRISTUS Health, which has 12 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05479929 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cough
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05479929's enrollment target sits among peer trials
39 9th of 12 higher than 4 of 12 other Cough trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cough trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough
RECRUITING · Phase 3
-
Office-Based Superior Laryngeal Nerve Block for Treatment of Neurogenic Cough
RECRUITING
-
The Mechanism Versus PPI Trial
RECRUITING · Phase 4
-
Stimulation of the Larynx to Treat Unexplained Chronic Cough
RECRUITING · NA
-
A 52-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough
ACTIVE NOT RECRUITING · Phase 3
-
Stimulation With Wire Leads to Restore Cough
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03465592 · 39 participants · Phase 1
Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma
- NCT03961776 · 39 participants
Monitoring Treatment Response With On-board DWI During Neo-adjuvant Chemo-radiation for Rectal Cancer Using Magnetic Resonance-guided-radiotherapy Systems
- NCT04050280 · 39 participants · Phase 2
CLAG-GO for Patients With Persistent, Relapsed or Refractory AML
- NCT04190862 · 39 participants · Phase 1
E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI